Your browser doesn't support javascript.
loading
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma.
Yu, Junjie; Pajvani, Utpal B.
Afiliação
  • Yu J; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
  • Pajvani UB; Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing, Jiangsu Province, China.
Med Rev (Berl) ; 2(6): 544-546, 2022 Dec.
Article em En | MEDLINE | ID: mdl-37724256
ABSTRACT
Non-alcoholic steatohepatitis (NASH) with metabolic syndrome is increasing to be a main cause of hepatocellular carcinoma (HCC). However, the mechanism of tumorigenesis in NASH induced HCC is still not clear. In this perspective, we will discuss the recent progress that has been made to understand the genetic change and the immune microenvironment of HCC, and the remaining questions. Based on the current study, NASH-HCC is likely to have novel mechanism, which needs more investigation in future.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Med Rev (Berl) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Med Rev (Berl) Ano de publicação: 2022 Tipo de documento: Article